Cytospire Therapeutics

Provider of immune cell engagers for treating cancer

placeLondon, England, United Kingdom calendar_todayFounded 2023 language cytospire.com

Social engagement

Social engagement: 1.6K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include 4Bio Capital.

Investor typeCountShare
Venture capital770%
Angel & family office110%
Bank & private debt110%
Other / undisclosed110%

Recent activity

10 Jun 2026
Leadership hire
Board of Directors
21 May 2026
Recognition
16 Apr 2026
Event
AACR Annual Meeting 2026
Coming soon